A Phase 1b Multiple Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms
Latest Information Update: 08 Oct 2021
At a glance
- Drugs Theralizumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors TheraMAB
- 05 Oct 2021 Status changed from recruiting to completed.
- 14 Feb 2017 Status changed from not yet recruiting to recruiting.
- 03 Jan 2017 New trial record